Terms: = Leukemia AND MDS2, Q8NDY4, 259283, ENSG00000197880
2 results:
1. STIMULUS-mds2 design and rationale: a phase III trial with the anti-TIM-3 sabatolimab (MBG453) + azacitidine in higher risk MDS and CMML-2.
Zeidan AM; Giagounidis A; Sekeres MA; Xiao Z; Sanz GF; Hoef MV; Ma F; Hertle S; Santini V
Future Oncol; 2023 Mar; 19(9):631-642. PubMed ID: 37083373
[TBL] [Abstract] [Full Text] [Related]
2. Fusion of ETV6 with an intronic sequence of the BAZ2A gene in a paediatric pre-B acute lymphoblastic leukaemia with a cryptic chromosome 12 rearrangement.
Panagopoulos I; Strömbeck B; Isaksson M; Heldrup J; Olofsson T; Johansson B
Br J Haematol; 2006 May; 133(3):270-5. PubMed ID: 16643428
[TBL] [Abstract] [Full Text] [Related]
